MyFastRx review

MyFastRx offers compounded semaglutide and tirzepatide with a straightforward continuing price, a first-month discount and several prepaid options. Its strongest practical feature is that it separates the introductory offer from the regular price and says there is no automatic billing. The website still contains some inconsistent product wording, so the prescription and final order deserve a closer read than the marketing headline.

For women seeking general weight management, this is a cash-pay option rather than a dedicated menopause or PCOS practice. This review evaluates the published program, prices and exit terms.

Introductory and continuing costs

Semaglutide is advertised at $69 for the first month, then $139 per month. Tirzepatide is $129 for the first month, then $199 per month. The $70 introductory saving is described as automatically applied on the special-offer page; product pages also reference code MY70. Confirm that the discount appears on the actual selected order rather than assume every path through the website uses the same offer.

The prepaid semaglutide ladder on the special page is $99 per month for three months, $89 for six months and $79 for twelve months. Those are monthly equivalents, with the longer plans billed upfront. Tirzepatide lists $498 for three months, $894 for six months and $1,488 for twelve months, equivalent to $166, $149 and $124 per month. The twelve-month price is therefore not a month-to-month purchase option.

The site states that the price is the same at any approved dose, with provider review, medication and free express shipping included. No membership fee or automatic billing is advertised. That is helpful if you want to avoid an additional care subscription, but it does not mean refills happen without action. Ask what reassessment is required, how early to request the next supply and whether the longer plan ships in installments or larger quantities.

MyFastRx does not accept insurance. The public price is a self-pay offer, not the copay for an approved brand. Someone whose insurance already covers Wegovy or Zepbound should compare her actual medication-and-care total rather than assume a low first-month compounded price will remain the least expensive route.

What is prescribed, and by whom?

The program is built around compounded injectable semaglutide and tirzepatide. A licensed U.S. provider reviews the online history and decides whether treatment is appropriate. MyFastRx says it does not manufacture medication; prescriptions are filled by licensed pharmacies. The reviewed pages do not establish an oral GLP-1 program or promise a brand-name prescription at these prices.

The product pages describe intake review within about twenty-four hours, followed by pharmacy processing after approval. The intake timing is an estimate, not a guarantee of next-day delivery. The company says medications usually ship Monday through Thursday to reduce weekend delays, with temperature-controlled packaging and tracking. If you are transferring providers, arrange the refill window before your current supply runs out.

There are copy inconsistencies worth knowing. The tirzepatide page contains several references to semaglutide in fulfillment sections and a semaglutide label next to its closing $129 offer. Those look like reused page wording, not evidence that the medication names are interchangeable. Ask for an order confirmation explicitly naming the prescribed ingredient, formulation, concentration, quantity and pharmacy.

The site displays a LegitScript certification badge. Such a credential can be a useful business-compliance signal, but it is not FDA approval of a compounded preparation and does not establish that your personal treatment will be effective. The company acknowledges that compounded medications are not FDA-approved. Our compounded versus brand-name guide explains the distinction when evaluating these choices.

Ongoing support and women's care

MyFastRx advertises unlimited clinical-team access for dosage questions and side-effect support, with approved dose changes included. The public offer does not publish a universal medical-message response guarantee or a fixed schedule of live follow-up appointments. Ask how to reach the prescribing clinician and what happens when a problem needs more than an administrative customer-service reply.

The multi-month page mentions quarterly doctor check-ins. That does not establish that all patients should wait three months to raise a concern or that every order includes the same visit schedule. Establish the clinical follow-up plan during the assessment, especially if you already have another prescriber managing diabetes, hormone therapy or other medication.

The pages reviewed do not lay out a distinct PCOS service. They do not promise menstrual management, fertility treatment or a full endocrine workup. For a woman with PCOS, the useful question is whether MyFastRx will coordinate weight management with the clinician treating those other concerns. Our GLP-1 and PCOS guide helps organize that conversation.

Likewise, the catalog centers on GLP-1 medication and NAD+, rather than a documented menopause HRT pathway. NAD+ marketing about energy or wellness does not establish treatment for hot flashes or a proven GLP-1 add-on benefit. If you want one team to manage both menopause symptoms and weight treatment, confirm that service explicitly instead of inferring it from a general wellness offering.

How easy is it to leave?

The website says there are no contracts or cancellation fees, and describes pausing or canceling before the next refill. Its no-automatic-billing statement makes the service different from a conventional recurring monthly subscription, but a prepaid purchase can still have refund conditions. Before committing to twelve months, obtain the current refund calculation for supplies already fulfilled and money remaining on the plan.

The current refund policy explains repricing used treatment at the shorter plan rate when a discounted prepay ends early, with medication dispensed in three-month supplies. That means a refund need not equal the annual monthly equivalent multiplied by the unused months. The calculation uses the prices in effect when you purchased, and there is no additional cancellation fee. Save a copy of those terms. Prescription fulfillment and future cancellation are separate events.

MyFastRx is a reasonable comparison for a woman wanting low continuing cash prices, flat dosing costs and no separate membership. Its weaker points are the unnamed assigned pharmacy, product-page copy inconsistencies and limited specialist women's-care detail. The best fit depends on the full plan and refill process, not the first-month promotion alone; our provider-selection guide can help compare those details.